The Tunisian startup Epilert is developing a wearable device for epilepsy detection using artificial intelligence.
The health aid monitors seizures based on a variety of physiological symptoms detected by a wrist bracelet. The data is then analyzed by doctors through the correspondent software. It is linked to an app that will notify an individual with epilepsy’s caregiver with an automated SMS and phone call when the Epilert technology detects a convulsive seizure.
Epileptic patients that use the gadget can log in to a separate app to keep track of their condition and use machine learning to predict when a seizure might occur. The device monitors the wearer’s skin temperature and movements and uses geolocation to call for help when needed. It also transmits data to the patient’s doctor so they can monitor the patient’s health and learn more about the condition. The bracelet is waterproof and can be worn 24 hours a day. A spokesman for the company explained:
“Our mission consists of using the latest high-tech evolutions in order to create effective stewardship of information resources and deliver secure, highly reliable healthcare technological solutions with a polished design along with high-quality, customer-oriented services and constant support. It is our duty to make sure that our products are up to the international standards.”
The company was co-founded by engineer Firas Rhaeim whose sister is epileptic. Having experienced the problems often faced by those living with the disorder first-hand, Rhaeim decided to develop a solution. Along with co-founders Haroun Moula and Amine Riahi, they came up with the wearable bracelet that has integrated biosensors for epilepsy and other neurological disorders.
The device is currently in the last stages of prototyping and has just begun clinical trials at the Al Razi Hospital in Manouba. The company hopes the device will be available to customers by February 2020.